My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1078

    1.

    Systemic TNF blockade does not modulate synovial expression of the pro-inflammatory mediator HMGB1 in rheumatoid arthritis patients--a prospective clinical study.

    Sundberg E, Grundtman C, Af Klint E, Lindberg J, Ernestam S, Ulfgren AK, Harris HE, Andersson U.

    Arthritis Res Ther. 2008;10(2):R33. Epub 2008 Mar 17.PMID: 18346273 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Effect of infliximab on mRNA expression profiles in synovial tissue of rheumatoid arthritis patients.

    Lindberg J, af Klint E, Catrina AI, Nilsson P, Klareskog L, Ulfgren AK, Lundeberg J.

    Arthritis Res Ther. 2006;8(6):R179.PMID: 17134501 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The value of synovial cytokine expression in predicting the clinical response to TNF antagonist therapy (infliximab).

    Buch MH, Reece RJ, Quinn MA, English A, Cunnane G, Henshaw K, Bingham SJ, Bejarano V, Isaacs J, Emery P.

    Rheumatology (Oxford). 2008 Oct;47(10):1469-75. Epub 2008 Jul 26.PMID: 18660510 [PubMed - indexed for MEDLINE]Related articles

    4.

    Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor.

    Ernestam S, af Klint E, Catrina AI, Sundberg E, Engström M, Klareskog L, Ulfgren AK.

    Arthritis Res Ther. 2006;8(1):R18.PMID: 16507118 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis.

    Catrina AI, af Klint E, Ernestam S, Catrina SB, Makrygiannakis D, Botusan IR, Klareskog L, Ulfgren AK.

    Arthritis Rheum. 2006 Jan;54(1):76-81.PMID: 16385498 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Intraarticular glucocorticoid treatment reduces inflammation in synovial cell infiltrations more efficiently than in synovial blood vessels.

    af Klint E, Grundtman C, Engström M, Catrina AI, Makrygiannakis D, Klareskog L, Andersson U, Ulfgren AK.

    Arthritis Rheum. 2005 Dec;52(12):3880-9.PMID: 16320336 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF alpha and IL18 but not CXCL12.

    van Oosterhout M, Levarht EW, Sont JK, Huizinga TW, Toes RE, van Laar JM.

    Ann Rheum Dis. 2005 Apr;64(4):537-43.PMID: 15769913 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Successful treatment of rheumatoid arthritis is associated with a reduction in synovial membrane cytokines and cell adhesion molecule expression.

    Smith MD, Slavotinek J, Au V, Weedon H, Parker A, Coleman M, Roberts-Thomson PJ, Ahern MJ.

    Rheumatology (Oxford). 2001 Sep;40(9):965-77.PMID: 11561106 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis.

    Badot V, Galant C, Nzeusseu Toukap A, Theate I, Maudoux AL, Van den Eynde BJ, Durez P, Houssiau FA, Lauwerys BR.

    Arthritis Res Ther. 2009;11(2):R57. Epub 2009 Apr 23.PMID: 19389237 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Overexpression of synoviolin in peripheral blood and synoviocytes from rheumatoid arthritis patients and continued elevation in nonresponders to infliximab treatment.

    Toh ML, Marotte H, Blond JL, Jhumka U, Eljaafari A, Mougin B, Miossec P.

    Arthritis Rheum. 2006 Jul;54(7):2109-18.PMID: 16802346 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF-alpha monoclonal antibody, infliximab.

    Sekiguchi N, Kawauchi S, Furuya T, Inaba N, Matsuda K, Ando S, Ogasawara M, Aburatani H, Kameda H, Amano K, Abe T, Ito S, Takeuchi T.

    Rheumatology (Oxford). 2008 Jun;47(6):780-8. Epub 2008 Apr 3.PMID: 18388148 [PubMed - indexed for MEDLINE]Related articles

    12.

    Responsiveness to anti-tumour necrosis factor alpha therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patients.

    van der Pouw Kraan TC, Wijbrandts CA, van Baarsen LG, Rustenburg F, Baggen JM, Verweij CL, Tak PP.

    Ann Rheum Dis. 2008 Apr;67(4):563-6. Epub 2007 Nov 27.PMID: 18042642 [PubMed - indexed for MEDLINE]Related articles

    13.

    The relationship between synovial lymphocyte aggregates and the clinical response to infliximab in rheumatoid arthritis: a prospective study.

    Klaasen R, Thurlings RM, Wijbrandts CA, van Kuijk AW, Baeten D, Gerlag DM, Tak PP.

    Arthritis Rheum. 2009 Nov;60(11):3217-24.PMID: 19877042 [PubMed - indexed for MEDLINE]Related articles

    14.

    The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor alpha expression in the synovium.

    Wijbrandts CA, Dijkgraaf MG, Kraan MC, Vinkenoog M, Smeets TJ, Dinant H, Vos K, Lems WF, Wolbink GJ, Sijpkens D, Dijkmans BA, Tak PP.

    Ann Rheum Dis. 2008 Aug;67(8):1139-44. Epub 2007 Nov 29.PMID: 18055470 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report.

    Catrina AI, Trollmo C, af Klint E, Engstrom M, Lampa J, Hermansson Y, Klareskog L, Ulfgren AK.

    Arthritis Rheum. 2005 Jan;52(1):61-72.PMID: 15641091 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Reduction of synovial sublining layer inflammation and proinflammatory cytokine expression in psoriatic arthritis treated with methotrexate.

    Kane D, Gogarty M, O'leary J, Silva I, Bermingham N, Bresnihan B, Fitzgerald O.

    Arthritis Rheum. 2004 Oct;50(10):3286-95.PMID: 15476228 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis.

    Barrera P, Joosten LA, den Broeder AA, van de Putte LB, van Riel PL, van den Berg WB.

    Ann Rheum Dis. 2001 Jul;60(7):660-9.PMID: 11406520 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synovium.

    Bramlage CP, Kaps C, Ungethüm U, Bramlage P, Koziolek M, Wessels J, Krenn V, Pruss A, Müller GA, Strutz F, Burmester GR, Häupl T.

    Scand J Rheumatol. 2008 Nov-Dec;37(6):401-9.PMID: 18830904 [PubMed - indexed for MEDLINE]Related articles

    19.

    Systemic anti-tumor necrosis factor alpha therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor alpha synthesis.

    Ulfgren AK, Andersson U, Engström M, Klareskog L, Maini RN, Taylor PC.

    Arthritis Rheum. 2000 Nov;43(11):2391-6.PMID: 11083259 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to tumour necrosis factor blockade.

    van Kuijk AW, Wijbrandts CA, Vinkenoog M, Zheng TS, Reedquist KA, Tak PP.

    Ann Rheum Dis. 2010 Jan;69(1):301-4. Epub .PMID: 19147618 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk